Table 5.
The functions and mechanisms of GPCR in other cells
| GPCR Name | GRAFS Classification | Ligand | Coupled G Protein Subtype | Signaling Pathway | Functional/Phenotypic Changes and references |
|---|---|---|---|---|---|
| A3AR (ADORA3) | Rhodopsin family - α subgroup (Adenosine) | Adenosine | Gαi | PKA-Akt-NF-κB inhibition | Suppresses osteosarcoma cell aggressiveness; inhibits tumor progression 124. |
| CaSR | Glutamate family | Extracellular Ca²⁺ | Gαq | Calcium signaling/NF-κB | Promotes migration and proliferation of bone-metastasizing renal cell carcinoma (RCC) cells; potential prognostic marker for RCC bone metastasis 122. |
| CB1 | Rhodopsin family - α subgroup (Cannabinoid) | Endocannabinoids, e.g., anandamide | Gαi | Pro-inflammatory cytokine signaling | Knockdown in Kupffer cells improves insulin sensitivity and reduces hepatic insulin resistance in obesity 125. |
| LPAR1 (EDG2/GPCR26) | Rhodopsin family - δ subgroup (Lipids) | Lysophosphatidic acid, LPA | Gα12/13 | NF-κB/MMP activation | SNP in EDG2 promoter enhances inflammatory cytokine and MMP expression; contributes to osteoarthritis pathogenesis 126. |
| GPR41 (FFAR3) | Rhodopsin family | Short-chain fatty acids, e.g., propionate | Gαi/Gαq (putative) | Calcium signaling | Enhances glucose uptake in muscle cells; improves insulin sensitivity and glucose tolerance in diabetic models 123. |
| GPR43 | Rhodopsin family | Short-chain fatty acids, e.g., propionate | Gαi | Anti-inflammatory signaling pathways | Reduce osteoarthritis cartilage inflammation and matrix destruction 103, 128. |
| GPRC5A | Glutamatefamily | Tretinoin | / | STAT3-dependent signaling | Knockout prevents bone metastasis in prostate cancer; correlates with Gleason score and metastasis in patients 127. |
| CXCR4 | Rhodopsin family | CXCL12 | Gαi | CXCL12/CXCR4-EMT axis | Promotes EMT-like changes and osteotropism in neuroendocrine tumor cells; CXCR4 silencing abrogates migration and metastasis 129. |